Status:
UNKNOWN
Dry Eye Evaluation System Based on Bioinformatics
Lead Sponsor:
Huaxia Eye Hospital Group
Conditions:
Dry Eye
Eligibility:
All Genders
10-90 years
Brief Summary
Dry eye is a common ocular surface disease of multifactorial etiology characterized by elevated tear osmolality and inflammation leading to a disrupted ocular surface. The latter is a risk factor for ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Dye Eye
Exclusion
- systemic disease (such as diabetes, glaucoma, or systemic collagen vascular disease), ocular disease, a history of tear supplement usage or contact lens wear during the past year,and pregnancy
Key Trial Info
Start Date :
September 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 23 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04109170
Start Date
September 23 2019
End Date
January 23 2020
Last Update
September 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huaxia Eye Hosptial of Foshan
Foshan, Guangdong, China, 528000